+关注
卷子爸
新鸟
IP属地：北京
24
关注
0
粉丝
0
主题
0
勋章
主贴
热门
卷子爸
2021-12-07
$鹰瞳科技-B(02251)$
说好的AI医疗第一股呢？什么玩意儿啊！
卷子爸
2021-12-20
那当初的发行价谁定的，这尼玛不是坑人吗？上来就割韭菜。
瑞银：首予鹰瞳科技(02251)“买入”评级 目标价75.20港元
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3477051193551003","uuid":"3477051193551003","gmtCreate":1513957172788,"gmtModify":1704447501647,"name":"卷子爸","pinyin":"jzbjuanziba","introduction":"","introductionEn":"","signature":"新鸟","avatar":"https://static.tigerbbs.com/3fec18b558225c9a74bfbe72db9d2218","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":24,"tweetSize":2,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.93%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.08%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":1,"location":"北京","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":7,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":693969177,"gmtCreate":1639961446517,"gmtModify":1639965490635,"author":{"id":"3477051193551003","authorId":"3477051193551003","name":"卷子爸","avatar":"https://static.tigerbbs.com/3fec18b558225c9a74bfbe72db9d2218","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3477051193551003","authorIdStr":"3477051193551003"},"themes":[],"htmlText":"那当初的发行价谁定的，这尼玛不是坑人吗？上来就割韭菜。","listText":"那当初的发行价谁定的，这尼玛不是坑人吗？上来就割韭菜。","text":"那当初的发行价谁定的，这尼玛不是坑人吗？上来就割韭菜。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693969177","repostId":"2192904375","repostType":2,"isVote":1,"tweetType":1,"viewCount":1079,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606183976,"gmtCreate":1638842794251,"gmtModify":1638842794251,"author":{"id":"3477051193551003","authorId":"3477051193551003","name":"卷子爸","avatar":"https://static.tigerbbs.com/3fec18b558225c9a74bfbe72db9d2218","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3477051193551003","authorIdStr":"3477051193551003"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02251\">$鹰瞳科技-B(02251)$</a>说好的AI医疗第一股呢？什么玩意儿啊！","listText":"<a href=\"https://laohu8.com/S/02251\">$鹰瞳科技-B(02251)$</a>说好的AI医疗第一股呢？什么玩意儿啊！","text":"$鹰瞳科技-B(02251)$说好的AI医疗第一股呢？什么玩意儿啊！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606183976","isVote":1,"tweetType":1,"viewCount":2520,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":606183976,"gmtCreate":1638842794251,"gmtModify":1638842794251,"author":{"id":"3477051193551003","authorId":"3477051193551003","name":"卷子爸","avatar":"https://static.tigerbbs.com/3fec18b558225c9a74bfbe72db9d2218","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3477051193551003","authorIdStr":"3477051193551003"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02251\">$鹰瞳科技-B(02251)$</a>说好的AI医疗第一股呢？什么玩意儿啊！","listText":"<a href=\"https://laohu8.com/S/02251\">$鹰瞳科技-B(02251)$</a>说好的AI医疗第一股呢？什么玩意儿啊！","text":"$鹰瞳科技-B(02251)$说好的AI医疗第一股呢？什么玩意儿啊！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606183976","isVote":1,"tweetType":1,"viewCount":2520,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693969177,"gmtCreate":1639961446517,"gmtModify":1639965490635,"author":{"id":"3477051193551003","authorId":"3477051193551003","name":"卷子爸","avatar":"https://static.tigerbbs.com/3fec18b558225c9a74bfbe72db9d2218","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3477051193551003","authorIdStr":"3477051193551003"},"themes":[],"htmlText":"那当初的发行价谁定的，这尼玛不是坑人吗？上来就割韭菜。","listText":"那当初的发行价谁定的，这尼玛不是坑人吗？上来就割韭菜。","text":"那当初的发行价谁定的，这尼玛不是坑人吗？上来就割韭菜。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693969177","repostId":"2192904375","repostType":2,"repost":{"id":"2192904375","kind":"news","pubTimestamp":1639960816,"share":"https://www.laohu8.com/m/news/2192904375?lang=&edition=full","pubTime":"2021-12-20 08:40","market":"us","language":"zh","title":"瑞银：首予鹰瞳科技(02251)“买入”评级 目标价75.20港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2192904375","media":"智通财经","summary":"智通财经APP获悉，瑞银发布研究报告称，首予鹰瞳科技“买入”评级，目标价75.20港元。视网膜影像AI尚处于早期发展阶段，但发展潜力巨大，市场规模有望于2025年达到47亿元。鹰瞳科技提供基于视网膜影像AI技术的疾病早期检测、诊断和健康风险评估方案，是该细分领域的领导者。","content":"<html><body><p>智通财经APP获悉，<a href=\"https://laohu8.com/S/UBS\">瑞银</a>发布研究报告称，首予<a href=\"https://laohu8.com/S/90050\">鹰瞳科技</a>(02251)“买入”评级，目标价75.20港元。 </p><p>视网膜影像AI尚处于早期发展阶段，但发展潜力巨大，市场规模有望于2025年达到47亿元。鹰瞳科技提供基于视网膜影像AI技术的疾病早期检测、诊断和健康风险评估方案，是该细分领域的领导者。</p><p>据悉，公司拥有强大的数据优势、丰富的产品管线以及多元的商业化销售网络。 \n长期来看，基于2030年视网膜影像AI市场规模可达340亿元的预测，如果鹰瞳科技持续成功地拓展更多的商业化渠道和客户，完成各项关键节点事件并超出预期，证明其执行力和更清晰的成长路径后，从DCF估值模型来看，鹰瞳科技股价的上升空间可达196.00港元。</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>瑞银：首予鹰瞳科技(02251)“买入”评级 目标价75.20港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n瑞银：首予鹰瞳科技(02251)“买入”评级 目标价75.20港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 08:40 北京时间 <a href=http://www.zhitongcaijing.com/content/detail/624957.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，瑞银发布研究报告称，首予鹰瞳科技(02251)“买入”评级，目标价75.20港元。 视网膜影像AI尚处于早期发展阶段，但发展潜力巨大，市场规模有望于2025年达到47亿元。鹰瞳科技提供基于视网膜影像AI技术的疾病早期检测、诊断和健康风险评估方案，是该细分领域的领导者。据悉，公司拥有强大的数据优势、丰富的产品管线以及多元的商业化销售网络。 \n长期来看，基于2030年视网膜影像AI...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/624957.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/d2a986280a0d0ac6d75b62fd1fec8874","relate_stocks":{"02251":"鹰瞳科技-B"},"source_url":"http://www.zhitongcaijing.com/content/detail/624957.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192904375","content_text":"智通财经APP获悉，瑞银发布研究报告称，首予鹰瞳科技(02251)“买入”评级，目标价75.20港元。 视网膜影像AI尚处于早期发展阶段，但发展潜力巨大，市场规模有望于2025年达到47亿元。鹰瞳科技提供基于视网膜影像AI技术的疾病早期检测、诊断和健康风险评估方案，是该细分领域的领导者。据悉，公司拥有强大的数据优势、丰富的产品管线以及多元的商业化销售网络。 \n长期来看，基于2030年视网膜影像AI市场规模可达340亿元的预测，如果鹰瞳科技持续成功地拓展更多的商业化渠道和客户，完成各项关键节点事件并超出预期，证明其执行力和更清晰的成长路径后，从DCF估值模型来看，鹰瞳科技股价的上升空间可达196.00港元。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1079,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
